{"id":45414,"date":"2017-09-29T14:31:34","date_gmt":"2017-09-29T19:01:34","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?page_id=45414"},"modified":"2019-01-12T06:49:07","modified_gmt":"2019-01-12T11:19:07","slug":"enfermedades-de-unidad-pilosebacea","status":"publish","type":"page","link":"https:\/\/piel-l.org\/blog\/educacion-online\/enfermedades-de-unidad-pilosebacea","title":{"rendered":"Enfermedades de Unidad Pilosebacea"},"content":{"rendered":"<div class=\"clear\"><\/div><div class=\"author-info\"><img decoding=\"async\" class=\"author-img\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2017\/09\/JaimePiquero.jpg\" alt=\"\" \/><div class=\"author-info-content\"><h3>Dr. Jaime Piquero-Mart\u00edn<\/h3>\n\t\t\tInstituto de Biomedicina- Hospital Vargas. \u000bCaracas Venezuela\n\t\t\t<\/div><\/div>\n<div class=\"su-divider su-divider-style-dotted\" style=\"margin:15px 0;border-width:1px;border-color:#eae9e9\"><\/div>\n<ul class=\"lesson-list\">\n<li><a href=\"http:\/\/piel-l.org\/blog\/44959\">1. ACNE 2017 Parte I: Fisiopatologia \u2013 Clinica<\/a> 23:54 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/45408\">2. ACNE 2017 Parte II: Terap\u00e9utica<\/a> 13:18 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/45454\">3. Dermatitis Seborreica. Generalidades (Parte 1)<\/a> 7:48 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\" http:\/\/piel-l.org\/blog\/45661\">4. Dermatitis Seborreica.Terapeutica (Parte 2)<\/a> 14:33 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/45975\">5. Ros\u00e1cea. Generalidades Etiopatogenia, comorbilidades (Parte 1)<\/a> 14:04 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/46028\">6. Ros\u00e1cea: Cl\u00ednica, clasificaci\u00f3n, diagn\u00f3stico (Parte 2)<\/a> 12:27 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/46030\">7. Ros\u00e1cea: Terapia actual (Parte 3)<\/a> 14:04 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/46196\">8. Hidradenitis supurativa. Etiopatog\u00e9nica, cl\u00ednica, comorbilidades (Parte 1)<\/a> 11:33 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/46194\">9. Hidradenitis supurativa. (Parte 2)<\/a> 09:56 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/45978\">10. Qu\u00e9 hay de nuevo en terapeutica de Acn\u00e9 (Dr. Juan Carlos Diez Medina ) <\/a> 12:39 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/45980\">11. Acn\u00e9 en la mujer Adulta un enfoque integral (Dr. Juan Carlos Diez Medina )<\/a> 21:19 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"https:\/\/piel-l.org\/blog\/46624\">12. Ros\u00e1cea: Alternativas Terap\u00e9uticas<\/a> 19:20 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"https:\/\/piel-l.org\/blog\/46988\">13. Actualizaci\u00f3n en acn\u00e9 2018<\/a> 20:00 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<li><a href=\"https:\/\/piel-l.org\/blog\/47162\">14. Dos casos de acn\u00e9 de dificil manejo (CILAD 2018)<\/a> 09:11 <i class=\"fa fa-youtube-play\"><\/i><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>1. ACNE 2017 Parte I: Fisiopatologia \u2013 Clinica 23:54 2. ACNE 2017 Parte II: Terap\u00e9utica 13:18 3. Dermatitis Seborreica. Generalidades (Parte 1) 7:48 4. Dermatitis Seborreica.Terapeutica (Parte 2) 14:33 5. Ros\u00e1cea. Generalidades Etiopatogenia, comorbilidades (Parte 1) 14:04 6. Ros\u00e1cea: Cl\u00ednica, clasificaci\u00f3n, diagn\u00f3stico (Parte 2) 12:27 7. Ros\u00e1cea: Terapia actual (Parte 3) 14:04 8. Hidradenitis supurativa. &hellip;<\/p>\n","protected":false},"author":16,"featured_media":0,"parent":45412,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-45414","page","type-page","status-publish",""],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/pages\/45414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=45414"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/pages\/45414\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/pages\/45412"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=45414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}